VKTX’s Innovative Drug Candidates Could Unlock Significant Value for Patients and Investors A recent study has shone new light on ...
Biotech company poised to lead FA treatment with innovative protein replacement therapy Larimar Therapeutics (LRMR) has emerged as a promising ...
The crypto exchange raises estimates for Q3 2024 amid stablecoin market recovery and regulatory optimism The cryptocurrency landscape has undergone ...
Server Share Gains and AI Expansion Counterbalance Gaming and PC Sector Weakness Advanced Micro Devices (AMD) is set to announce ...
Strategic Partnership Marks a Major Step in Diversifying Revenue Sources SoFi Technologies (SOFI), an online bank with a vision of ...
AI Leadership and Strong Demand Drive Growth Projections Nvidia's (NVDA) stock is making a strong comeback, climbing 13% this month ...
Better Loan Performance and Diversified Funding Set the Stage for a Stronger 2H’24 Upstart Holdings (UPST), a company known for ...
Reduced Funding Costs and GMV Growth to Bolster the Buy Now, Pay Later Pioneer Shares of Affirm Holdings (AFRM), a ...
Targeted radiopharmaceuticals promising multiple catalysts and clinical advancements heading into 2024 CATX (CATX), a company pioneering targeted radiopharmaceutical therapies, provided ...
Targeting H1047R Mutations for Improved Efficacy and Reduced Toxicity in an Expanding Market OnKure Therapeutics (OKUR) is making waves in ...
